Please login to the form below

Not currently logged in
Email:
Password:

New Accounts, February, 2007 - Advertising

The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period November 2006 to January 2007 inclusive

The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period November 2006 to January 2007 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets.

To submit an entry for New Accounts, email new_accounts@pmlive.com

Actavis

Accumulator

Generic medicines business

Woolley Pau

Alliance Pharmaceuticals

Isprelor

Obstetrics and gynaecology

Hanson Zandi

Ardana

Emselex

Urology

Life

Merial

Rabisin

Rabies vaccine

Roundhouse HealthAd

Merz

Xeomin and Belotero

Dermatology

Roundhouse HealthAd

Sanofi Pasteur MSD

Pneumovax II

Pneumococcal vaccine

Woolley Pau

SD Healthcare

Myiasert

Ophthalmology

Courts Design

Serono

Gonal-F

Infertility

Huntsworth Health

Teva UK

Clozapine

Anti-psychotic

Courts Design

ZLB Behring (Global)

Haemate P

Haematology

Hanson Zandi

ZLB Behring (Global)

Rhophylac

Obstetrics and gynaecology

Hanson Zandi

2nd September 2008

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Onyx Health Ltd

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...

Latest intelligence

What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
...
Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...

Infographics